FRA:ACT (Germany)
Â
Akt. nach Kapitalherabsetzung
€
47.20
(+0.64%)
Apr 24
Business Description
AlzChem Group AG
SIC : 7370
ISIN : DE000A2YNT30
Share Class Description:
FRA:ACT: Akt. nach KapitalherabsetzungDescription
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | 0.76 | |||||
| Interest Coverage | 7.52 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.65 | |||||
| Beneish M-Score | -2.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.5 | |||||
| 3-Year EBITDA Growth Rate | 14.7 | |||||
| 3-Year EPS without NRI Growth Rate | 20.7 | |||||
| 3-Year FCF Growth Rate | 54.1 | |||||
| 3-Year Book Growth Rate | 34.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.95 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 96.31 | |||||
| 9-Day RSI | 93.53 | |||||
| 14-Day RSI | 90.39 | |||||
| 6-1 Month Momentum % | 68.69 | |||||
| 12-1 Month Momentum % | 76.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.62 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 196.72 | |||||
| Days Sales Outstanding | 43.95 | |||||
| Days Payable | 58.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.24 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 11.9 | |||||
| Forward Dividend Yield % | 2.56 | |||||
| 5-Year Yield-on-Cost % | 2.27 | |||||
| Shareholder Yield % | 6.12 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.73 | |||||
| Operating Margin % | 10.65 | |||||
| Net Margin % | 6.4 | |||||
| FCF Margin % | 12.74 | |||||
| ROE % | 22.76 | |||||
| ROA % | 8.12 | |||||
| ROIC % | 10.78 | |||||
| ROC (Joel Greenblatt) % | 19.18 | |||||
| ROCE % | 17.36 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.64 | |||||
| Forward PE Ratio | 11.33 | |||||
| PE Ratio without NRI | 13.64 | |||||
| Shiller PE Ratio | 4.67 | |||||
| Price-to-Owner-Earnings | 8.89 | |||||
| PEG Ratio | 1.25 | |||||
| PS Ratio | 0.87 | |||||
| PB Ratio | 2.93 | |||||
| Price-to-Tangible-Book | 3.04 | |||||
| Price-to-Free-Cash-Flow | 6.87 | |||||
| Price-to-Operating-Cash-Flow | 6.51 | |||||
| EV-to-EBIT | 9.46 | |||||
| EV-to-Forward-EBIT | 8.39 | |||||
| EV-to-EBITDA | 6.47 | |||||
| EV-to-Forward-EBITDA | 5.85 | |||||
| EV-to-Revenue | 0.99 | |||||
| EV-to-Forward-Revenue | 0.92 | |||||
| EV-to-FCF | 7.57 | |||||
| Price-to-Projected-FCF | 0.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.27 | |||||
| Price-to-Graham-Number | 1.37 | |||||
| Earnings Yield (Greenblatt) % | 10.57 | |||||
| FCF Yield % | 14.35 | |||||
| Forward Rate of Return (Yacktman) % | 17.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AlzChem Group AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 540.65 | ||
| EPS (TTM) (€) | 3.41 | ||
| Beta | 0.83 | ||
| Volatility % | 45.08 | ||
| 14-Day RSI | 90.39 | ||
| 14-Day ATR (€) | 1.186823 | ||
| 20-Day SMA (€) | 42.305 | ||
| 12-1 Month Momentum % | 76.25 | ||
| 52-Week Range (€) | 17.7 - 47.2 | ||
| Shares Outstanding (Mil) | 10.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AlzChem Group AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AlzChem Group AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
AlzChem Group AG Frequently Asked Questions
What is AlzChem Group AG(FRA:ACT)'s stock price today?
The current price of FRA:ACT is €47.20. The 52 week high of FRA:ACT is €47.20 and 52 week low is €17.70.
When is next earnings date of AlzChem Group AG(FRA:ACT)?
The next earnings date of AlzChem Group AG(FRA:ACT) is .
Does AlzChem Group AG(FRA:ACT) pay dividends? If so, how much?
The Dividend Yield %  of AlzChem Group AG(FRA:ACT) is 2.24% (As of Today), Highest Dividend Payout Ratio of AlzChem Group AG(FRA:ACT) was 0.52. The lowest was 0.29. And the median was 0.39. The  Forward Dividend Yield % of AlzChem Group AG(FRA:ACT) is 2.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers